Here are relevant reports on : oncology-diagnostics-market
-
Veterinary CT Scanner Market by Type (Multi Slice CT Scanner, Portable CT Scanner), Animal (Small Animals, Equine, Livestock), Application (Neurology, Oncology, Orthopedic, Traumatology), End User (Animal Hospital, Clinic) - Global Forecast to 2022
The veterinary CT scanner market is expected to reach USD 173.7 Million by 2022 from an estimated USD 122.3 Million in 2017, at a CAGR of 7.3%. The key players in the global veterinary CT scanner market are GE Healthcare (US), Canon, Inc. (Toshiba Medical Systems Corporation) (Japan), Siemens AG (Siemens Healthineers) (Germany), Samsung Electronics Co. Ltd. (NeuroLogica Corporation) (South Korea), Epica Medical Innovation (US), Hitachi, Ltd. (Japan), Koninklijke Philips N.V. (Netherlands), Animage, LLC (US), GIN ApS (Denmark), QR s.r.l. (Italy), and 4DDI (US).
- Published: August 2017
- Price: $ 4950
- TOC Available:
-
Specialty PACS Market by Type (Radiology, Orthopedics, Oncology, Pathology, Endoscopy, Women's Health), Deployment Model (On premise, Cloud), Component (Software, Service), End User (Hospital, Clinic, Diagnostic Centers, Research) - Global Forecasts to 2024
The global specialty PACS market size is projected to reach USD 3.5 billion in 2024, at a CAGR of 6.0%. Some of the prominent players offering in this market includes IBM Corporation (Merge Healthcare Incorporated) (US), McKesson Corporation (US), Agfa Healthcare (Belgium), Carestream Health (a part of Onex Corporation) (Canada), Philips Healthcare (Netherlands), Sectra AB (Sweden), Siemens Healthineers (Germany), Novarad (US), INFINITT North America (US), Intelerad Medical Systems (Canada), Topcon Corporation (Japan), Sonomed Escalon (US), Canon USA, Inc. (US) (a subsidiary of Canon Inc.), Visbion (UK), and EyePACS, LLC (US).
- Published: September 2019
- Price: $ 4950
- TOC Available:
-
Enteral Feeding Formulas Market by Product (Polymeric, Elemental, Disease-specific), Stage (Adults, Pediatrics), Application (Oncology, Gastroenterology, Neurology, Hypermetabolism), End User (Hospitals, LTCF, Home care) & Region - Global Forecast to 2027
The global enteral feeding formulas market growth is primed to transition from $5.2 billion in 2022 to $8.2 billion by 2027, showcasing a strong CAGR of 9.5%. Factors such as rising healthcare expenditure; a surge in the number of preterm births worldwide; growing aging population in need for enteral feeding; rising prevalence of chronic diseases such as diabetes, cancer, gastrointestinal diseases, and neurological disorders; growing awareness of enteral nutrition benefits; and rapid improvements in healthcare facilities in emerging countries are expected to further drive the market during the forecast period.
- Published: August 2022
- Price: $ 4950
- TOC Available:
-
Rat Model Market by Model Type (Outbred, Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology, Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End User -Global Forecast to 2021
The global rat model market is projected to grow at a CAGR of 8.7%. Continuous support in the form of investments and grants, and personalized medicine fueling the demand for personalized humanized rat models are some of the factors driving the growth of the rat model market. In addition to this, increase in R&D activities in pharmaceutical industries is further stimulating the market growth.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2027
The global bioanalytical testing services market growth is primed to transition from $2.9 billion in 2022 to $6.0 billion by 2027, showcasing a strong CAGR of 15.6%. The major factors influencing the growth of the market include the well-established pharmaceutical industry, the strong presence of major service providers, the large number of ongoing clinical trial studies, high R&D expenditure, growth in the biosimilars and generics markets, and the rise in the outsourcing of preclinical, clinical, and laboratory testing services by pharmaceutical and biopharmaceutical companies in the region.
- Published: June 2022
- Price: $ 4950
- TOC Available:
-
Contrast Enhanced Ultrasound Market by Product (Equipment, Nanoparticle & Molecule-targeted Microbubbles, Software], Application (Diagnostic, Therapeutic, CVDs, Liver, Kidney, Oncology), End User (Hospital, Clinics, ASCs) & Region - Global Forecast to 2028
The global contrast enhanced ultrasound market, valued at US$1.4 billion in 2022, stood at US$1.6 billion in 2023 and is projected to advance at a resilient CAGR of 6.1% from 2023 to 2028, culminating in a forecasted valuation of US$2.1 billion by the end of the period. The rising use of contrast agents, increasing partnerships and collaborations, and the introduction of novel technologies are expected to drive the market during the forecast period.
- Published: August 2023
- Price: $ 4950
- TOC Available:
-
Surgical Lasers Market by product type (Carbon Dioxide, Argon, Nd:YAG & Diode Lasers), Procedure (Open, Laparoscopic & Percutaneous), & Application (Ophthalmology, Urology, Gynaecology, Dermatology, Dental, Cardiology, & Oncology) - Global forecast to 2021
The global surgical lasers market is projected to grow at a CAGR of 5.1%. The rising demand for surgical lasers can be attributed to the growing prevalence of chronic diseases, technological advancements, increasing incidence and prevalence of targeted diseases, and high prevalence of ophthalmic disorders. In addition, growing preference for minimally invasive surgeries among patients and healthcare professionals is supporting the growth of the surgical lasers market.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
US Electrosurgery Market by Product [Instruments (Bipolar, Monopolar), Accessories, Generators, Smoke Evacuation Systems], Surgery (Orthopedic, Cosmetic, Oncology, Urology, Neurology), End User (Hospitals, Ambulatory Surgical Centers) - Forecast to 2031
The US electrosurgery market, valued at US$2.80 billion in 2025, stood at US$2.94 billion in 2026 and is projected to advance at a resilient CAGR of 7.0% from 2026 to 2031, culminating in a forecasted valuation of US$4.13 billion by the end of the period. The US electrosurgery market is experiencing strong growth, mainly driven by the increasing preference for minimally invasive surgery across various specialties, which requires the use of precise electrosurgical instruments.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Guidewires Market by Material (Nitinol, Stainless Steel, Hybrid), Product (Surgical, Diagnostic (Hydrophilic, Hydrophobic)), Application (Cardiology, Vascular, Neurology, GIT, ENT, Urology, Oncology), End User (Hospital, ASCs) - Global Forecast to 2022
The global guidewires market is projected to reach USD 764.0 Million by 2022 from USD 605.2 Million in 2017, at a CAGR of 4.8%. The growth witnessed by guidewires is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for guidewires across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Abbott (US), Medtronic (Ireland), Terumo (Japan), and Cook Group (US). Other prominent players present in this market include Cardinal Health (US), Olympus (Japan), Johnson & Johnson (US), B. Braun (Germany), C.R. Bard (US), Teleflex (US), and Angiodynamics (US).
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
Europe Electrosurgery Market By Product (Instruments, Accessories, Generators, Smoke Evacuation Systems), Surgery (Cardiovascular, Orthopedic, Cosmetic, Oncology, Urology), End User (Hospitals, Ambulatory Surgical Centers) - Regional Forecast to 2031
The Europe electrosurgery market, valued at US$2.26 billion in 2024, stood at US$2.42 billion in 2025 and is projected to advance at a resilient CAGR of 5.3% from 2025 to 2031, culminating in a forecasted valuation of US$3.31 billion by the end of the period. The growth of the market is driven by the rising surgical volumes, an expanding elderly population, strong healthcare spending, and rapid adoption of advanced, safety-focused energy platforms across hospitals and specialty centers.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
